Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Sanofi Consumer Healthcare India Limited ( (IN:SANOFICONR) ).
Sanofi Consumer Healthcare India Limited has announced a significant agreement involving its promoter, Sanofi, and Clayton, Dubilier & Rice (CD&R) Group. The CD&R Group has agreed to acquire a controlling stake in Opella Healthcare SAS, subject to Sanofi’s decision to proceed with the acquisition. This move could potentially impact the company’s operations and industry positioning, as it involves a major shift in ownership structure.
More about Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited operates in the healthcare industry, primarily focusing on consumer healthcare products. The company is a significant player in the market, leveraging its expertise and extensive portfolio to cater to diverse healthcare needs.
YTD Price Performance: -3.32%
Average Trading Volume: 441
Current Market Cap: 108.2B INR
See more data about SANOFICONR stock on TipRanks’ Stock Analysis page.